FDA Investigator Pete Amin (Pankaj)
Pete Amin (Pankaj) has inspections in 2 countries as of 08 Sep 2023. Pete Amin (Pankaj) has collaborated with a combined 840 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
08 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Germany
Co-Investigator(s):
Bo Chi, PhD,
Bonita S Chester,
Brenda W Uratani, PhD,
Candace Y Gomez Broughton,
Donald C Obenhuber, PhD,
Dr. Carmelo Rosa,
Dr. Robert C Horan, MD,
Ellen P Madigan,
Hector A Carrero,
Jacek Cieslak, PhD,
John S Hartford,
Kalavati Suvarna, PhD,
Karen E D'orazio,
Kim Lthomas Cruse,
L Norwood,
Laurel A Beer,
Laurie Graham,
LCDR Debra Emerson,
Lori A Holmquist,
M Pedgen,
Mariza M Jafary,
Marlene G Swider,
Mary E Farbman, PhD,
Mary Jeanet Mcgarry,
Megan A Haggerty,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Mra Davism,
Nutan Mytle,
Obinna R Echeozo,
Pankaj H Amin,
Patricia Fhughes Troost,
Paul A Bonneau,
Ramon E Martinez,
Ranjani Prabhakara,
Rashmi Rawat, PhD,
Robert J Martin,
Roger F Zabinski,
Rose M Ashley,
Scott R Nichols, PhD,
Sean R Marcsisin,
Stacey S Degarmo,
Susant Hadman,
Toyin B Oladimeji,
Victoria A Wagoner,
Wayne E Seifert
Pete Amin (Pankaj)'s Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2019 | EIR | IDT Biologika GmbH - EIR, 2019-03-08 |
October, 2021 | FDA 483 | Lonza Biologics, Inc. - Form 483, 2021-10-22 |
March, 2019 | FDA 483 Response | IDT Biologika GmbH - Form 483R, 2019-03-25 |
March, 2019 | FDA 483 | IDT Biologika GmbH - Form 483, 2019-03-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more